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Edited by Gianni CesareniAbstract The spatial and temporal targeting of proteins or pro-
tein assemblies to appropriate sites is crucial to regulate the spec-
iﬁcity and eﬃciency of protein–protein interactions, thus dictating
the timing and intensity of cell signaling and responses. The resul-
tant dynamic mass redistribution could be manifested by label free
optical biosensor, and lead to a novel and functional optical signa-
ture for studying cell signaling. Here we applied this technology,
termed as mass redistribution cell assay technology (MRCAT), to
study the signaling networks of bradykinin B2 receptor in A431
cells. Using MRCAT, the spatial and temporal relocation of pro-
teins and protein assemblies mediated by bradykinin was quanti-
tatively monitored in microplate format and in live cells. The
saturability to bradykinin, together with the speciﬁc and dose-
dependent inhibition by a B2 speciﬁc antagonist HOE140, sug-
gested that the optical signature is a direct result of B2 receptor
activation. The sensitivity of the optical signature to cholesterol
depletion by methyl-b-cyclodextrin argued that B2 receptor
signaling is dependent on the integrity of lipid rafts; disruption
of these microdomains hinders the B2 signaling. Modulations of
several important intracellular targets with speciﬁc inhibitors
suggested that B2 receptor activation results in signaling via at
least dual pathways – Gs- and Gq-mediated signaling. Remark-
ably, the two signaling pathways counter-regulate each other.
Several critical downstream targets including protein kinase C,
protein kinase A, and epidermal growth factor receptor had been
identiﬁed to involve in B2 signaling. The roles of endocytosis and
cytoskeleton modulation in B2 signaling were also demonstrated.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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doi:10.1016/j.febslet.2005.10.019typically aﬀects the functionality of speciﬁc target(s) includingG
protein-coupled receptors (GPCRs), thus resulting in the execu-
tion of various cellular machineries in order for the cell to
accommodate such signal. Much information is available for
the signaling of GPCRs via either G protein-dependent or
independent mechanisms after many decades of experiments.
However, because of its complexity, the network interactions
of GPCR signaling are still far from being complete.
Intracellular macromolecules including proteins and molec-
ular assemblies are highly organized [1,2] and spatially re-
stricted to appropriate sites in mammalian cells [3,4]. The
localization of proteins is tightly controlled in order for cells
to regulate the speciﬁcity and eﬃciency of proteins interacting
with their proper partners, to spatially separate protein activa-
tion and deactivation mechanisms, and thus to determine spe-
ciﬁc cell functions and responses. In response to exogenous
stimuli, multiple signaling molecules or molecular assemblies
translocate to speciﬁc micro-compartment(s) of function at
appropriate time. The protein translocation enables the precise
control in the amplitude, duration and kinetics of cell signaling
through a speciﬁc target [5–10], such as a GPCR. Ligand bind-
ing initiates changes in receptor conformational and oligomer-
izational states [11,12]. The functional change in receptor
properties leads to dynamic interactions with regulatory mole-
cules at the cell plasmon membrane, and traﬃcking of many
molecules and molecular assemblies including the receptors
to appropriate cellular compartments at various stages of the
life cycle of a GPCR [9,13]. Such a movement results in dyna-
mic redistribution of cellular contents, equivalent to dynamic
mass redistribution (DMR). The DMR signal, manifested by
optical biosensor, was ﬁrst identiﬁed in our previous studies
on cytoskeleton modulation [2] and epidermal growth factor
(EGF) receptor signals [14]. The DMR signal is a novel quan-
tiﬁable and global representation signature for cell signaling,
leading to the development of a label free cell assay technolo-
gies, termed as mass redistribution cell assay technology
(MRCAT). The DMR signals mediated through a speciﬁc
molecule (e.g., EGFR) is an integrated cellular response that
involves multiple pathways and cellular events (e.g., cytoskele-
ton rearrangement, and/or movement of signaling cascade pro-
teins). Unlike conventional methods which are generally
limited to measurements of a single signaling event including
direct visualization of the movement of ﬂuorescently tagged
targets in cells [15–17], MRCAT utilizes the integrated signa-
ture of dynamic mass redistribution to study cell signaling
and the network interactions in cell signaling.
Here, we applied MRCAT to globally analyze the network
interactions of bradykinin B2 receptor in A431 cells. B2 recep-
tors are expressed constitutively on many cell types, andblished by Elsevier B.V. All rights reserved.
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action of bradykinin (BK) [18,19]. Human epidermoid carci-
noma A431 cells endogenously express bradykinin B2 receptor,
but not B1 receptor [20]. In A431, signaling mediated via
B2 receptor is well documented, and involves dual pathways
[21–24]: Gq-mediated stimulation of phosphoinositide hydroly-
sis resulting in a rapid activation of protein kinase C (PKC),
and Gs-mediated stimulation of cyclic AMP leading to protein
kinase A (PKA) pathway. However, the cellular mechanisms
of network interactions of B2 receptor signaling remain mostly
unknown. The study described here was the ﬁrst experimental
attempt at the global level to address the signaling and net-
work interactions of GPCRs in living cells.2. Materials and methods
2.1. Regents
Latrunculin A, cytochalasin B, phalloidin, nocodazole, methyl-b-
cyclodextrin, probenicid, EGTA (ethylene glycol-bis(2-aminoethyle-
ther)-N,N,N 0,N 0-tetraacetic acid), BAPTA-AM (1,2-bis(2-aminophen-
oxy)ethane-N,N,N 0,N 0-tetraacetic acid tetrakis (acetoxymethyl ester)),
and EGF were purchased from Sigma Chemical Co. (St. Louis,
MO). 8-Bromo-cAMP, forskolin, GF109203x, KT 5720, NKH447,
SB203580, SP600125, U0126, cell permeable dynamin inhibitor peptide
control (DIPC), R()-rolipram, zardaverine, and milrinone were
obtained from Tocris Chemical Co. (St. Louis, MO). Fluo-3 was obtai-
ned from Molecular Probes (Eugene, OR). HOE140 and des-Arg10-
HOE140 were obtained from Bachem (King of Prussia, PA). Corning
Epice 96 well biosensor microplates were obtained from Corning Inc
(Corning, NY), and cleaned by exposure to high intensity UV light
(UVO-cleaner, Jelight Company Inc., Laguna Hills, CA) for 6 min
before use.2.2. Cell Culture
Human epidermoid carcinoma A431 cells (American Type Cell Cul-
ture) were grown in Dulbeccos modiﬁed Eagles medium (DMEM)
supplemented with 15% fetal bovine serum (FBS), 4.5 g/l glucose,
2 mM glutamine, and antibiotics. 3–7.5 · 104 cells suspended in
200 ll the DMEM medium containing 15% FBS were placed in each
well of a 96 well biosensor microplate, and were cultured at 37 C un-
der air/5% CO2 until 95% conﬂuency was reached (2–4 days). The
cells were then subject to starvation using the corresponding medium
for about 20 h. To ensure the quality and density of cells on the sur-
faces of sensor microplates, the resulted quiescent cells were examined
with light microscopy before assays.2.3. Optical biosensor measurements
Corning Epice angular interrogation system with transverse mag-
netic or p-polarized TM0 mode was used for all studies. The details
of both instrument and assay protocol were previously described
[2,14]. Brieﬂy, after culturing under appropriate conditions the cells
were washed twice and maintained with 100 ll of 1· HBSS (1· regular
Hanks balanced salt solution, 20 mM HEPES buﬀer, pH 7.0). After-
wards, the sensor microplate containing cells was placed into the opti-
cal system, and the cell responses were recorded before and after
addition of a solution. For compound studies, the cells in each well
were pretreated with a compound solution of 50 ll or the 1· HBSS
until a steady phase (i.e., no obvious mass redistribution) was reached
(generally within 1 h), before BK solution of 50 ll was introduced. The
compound or BK solutions were made in 1· HBSS in order to match
the refractive index between the cell medium and compound solution,
thus minimizing the unwanted eﬀect of bulk index change due to the
introduction of compound solution which can temporarily overwhelms
any DMR signal as it occurs. Since the baseline of the responses varied
from well to well, we normalized the BK response in the absence or
presence of a compound at the time when the cells are in steady state
before BK treatment. All studies were carried out at room temperature
with the lid of the microplate on except for a short period of time
(seconds) when the solution was introduced, in order to minimize
the eﬀect of temperature ﬂuctuation and evaporative cooling.Besides monitoring in real time the changes in angle of the reﬂected
light, the angular interrogation system has ability to collect the reso-
nant band images and resonant peaks of all sensors at any time dur-
ing the assays. Since either the width or position of the resonant
band, or the peak-width at half-maximum (PWHM) of the resonant
peak of each sensor is sensitive to the cell density and viability [25],
the biological status of cells (e.g., cell viability, cell density, and
degree of adhesion) that could signiﬁcantly impact the assay results
can be examined and were taken into account for data analysis
[14], resulting in reduced assay variability. The unit of the responses
indicated throughout this paper was a change in pixel of the central
position of the resonant band of each sensor as imaged by the CCD
camera; 1 U equals to 5.82 · 104 refractive index changes, based
on an experimental normalization protocol, which uses the concen-
tration-dependent responses of both glycerol and dimethyl sulfoxide,
since both solutions have well-characterized refractive index value
(data not shown).2.4. Intracellular Ca2+ measurements
A431 at passage 3–5 were grown in either the biosensor microplate
or Costare 96 well clear cell culture microplates until 95% conﬂu-
ency, washed twice and starved overnight with the DMEM only,
washed with assay buﬀer containing 1· HBSS buﬀer in the presence
of 2.5 mM probenicid, and labeled in the same buﬀer containing
4 lM Fluo-3 for 1 h at 37 C and 5% CO2. The cells were then washed
twice with buﬀer, maintained with 100 ll of 1·HBSS, and treated with
a compound solution or 1·HBSS of 50 ll for 1 h at room temperature.
The assay was initiated by transferring 50 ll BK solution to the cell
plate, and calcium signal was recorded over 6 min with a 6 s interval
using HTS7000 BioAssay Reader (Perkin–Elmer Life Science, Boston,
MA). Four replicate examples were examined. The assays were carried
out at room temperature in order to allow direct comparison with opti-
cal sensing data.2.5. Statistical analysis
At least three replicates were carried out for each measurement or
each compound. The standard deviation was derived from these mea-
surements (n P 3). The graphs presented in ﬁgures were representa-
tive from at least three independent measurements.3. Results
3.1. BK stimulation triggers a dose-dependent and unique optical
signature in quiescent A431 cells
In quiescent A431 cells (0.05% FBS, 20 h), BK stimulation
led to a dose-dependent optical signature (Fig. 1A). At lower
doses (664 nM), the DMR signature consisted of two peaks
– a rapid peak and a retarded peak with much smaller ampli-
tude, each had a positive phase with increased signal (P-DMR)
followed by a decayed phase (N-DMR). The amplitudes of
both P- and N-DMR signals of the rapid peak were saturable
to BK concentrations, yielding a jd of 6.5 ± 1.6 nM (n = 3)
(Fig. 1B). This was consistent with the results based on Ca2+
mobilization measurements with Fluo-3. As showed in
Fig. 1C, BK stimulation led to a dose dependent Ca2+ mobili-
zation, resulting in a jd of 10.0 ± 2.8 nM (n = 3), consistent
with the value of 6 nM reported in the literature [22].
Companied with the increasing amplitudes, the kinetics of
the two phases of either peaks also increased, as the concentra-
tion of BK increases. Because of the known and distinct kinet-
ics of Gs and Gq-mediated signaling of B2 receptor in A431
cells, we hypothesized that the rapid peak is related to the
DMR associated with Gq-mediated signaling, whereas the sec-
ond and delayed peak is related to the DMR associated with
Gs-mediated signaling. Interestingly, as the concentration of
BK increases the time for reaching the center position of each
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Fig. 1. The dose-dependent optical signatures and Ca2+ mobilization of quiescent A431 cells obtained with 0.05% FBS in response to BK
stimulation. (A) The BK dose-dependent optical signals of cells as a function of time. (B) The amplitudes of the P-DMR phase of the rapid peak
mediated by BK were plotted as a function of BK concentration. (C) The percentage increases in intracellular Ca2+ level, manifested by the
ﬂuorescence intensity of Ca2+ obtained with Fluo-3, as a function of BK concentration. (D) The time-dependent responses of quiescent A431 cells in
response to high dose BK stimulation. The ﬁnal concentrations of BK used were indicated in the graphs.
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second peak eventually disappeared and the amplitude of the
rapid peak was increased by at least 50 ± 5.4% (n = 4) at
625 nM (Fig. 1D). One possible mechanism is that at high
doses BK stimulation attenuates the stimulation of adenylyl
cyclase [20], thus increasing the amplitude of Gq-mediated
signaling because the counteracting nature of Gs- against
Gq-mediated signaling via B2 receptor in A431. Alternatively,
high dose BK stimulation might result in the switching of Gs
to Gi signaling, probably through the BK-induced membrane
recruitment of phosphodiesterase isoform 4 (PDE4) to arres-
tins [26–28].
3.2. BK-mediated optical signature depends on cell states
In proliferating A431 cells (15% FBS) BK stimulation led to
substantially diﬀerent dose-dependent optical signature (Fig. 2).
At lower doses (<50 nM), there was only a slowly increased
DMR response, similar to those induced by either forskolin
or NKH447, suggesting that at low doses Gs-mediated signal-
ing is preferentially activated. Both forskolin and NKH447 are
two adenylyl cyclase activators, leading to the activation of
PKA pathway [29]. However, at higher doses (P50 nM)BK stimulation appears only lead to the rapid peak, probably
due to the Gq-mediated pathway being activated. Most likely,
growth factors in the growth medium activate EGFRs or other
targets in the cells, leading to a growth state that disfavors the
Gs signaling pathway [21], when high dose BK was used to
stimulate the cells.
3.3. BK-mediated optical signature is speciﬁc to B2 receptor
activation
To examine the speciﬁcity of the BK-mediated optical signals,
the quiescent A431 cells were pretreated with either a potent and
speciﬁc B2 receptor antagonist HOE 140 or a B1-speciﬁc antag-
onist des-10Arg-HOE 140 [30,31], and subsequently stimulated
with 16 nM BK. The pretreatment of cells with HOE 140, but
not des-Arg10-HOE 140, speciﬁcally and completely abolished
the DMR response mediated by 16 nM BK (Fig. 3A). The inhi-
bition of the BK response byHOE140 was found to be in a dose-
dependent manner with an IC50 of 40.2 ± 1.3 nM (n = 3)
(Fig. 3B), corresponding to a ji value of 11.5 ± 0.40 nM using
the obtained jd. Together with the saturability to BK concen-
tration, these results suggested that the BK-induced optical
response is speciﬁc to the activation of B2 receptors.
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Fig. 2. The time-dependent optical signals of proliferating A431 cells
obtained with 15% FBS before and after stimulation with diﬀerent
doses of BK. The concentrations of BK from (b) to (f) were 1, 5, 25,
125 and 625 nM, respectively. The time-dependent response of
proliferating cells stimulated with 10 lM forskolin only (a) was also
presented for comparison.
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Fig. 3. The eﬀect of bradykinin receptor antagonists. (A) The dynamic
responses of quiescent A431 cells before and after treatment with
16 nM BK, in the absence and presence of compounds: des-Arg10-
HOE 140 and HOE 140. Both were at 1 lM. (B) The amplitudes of the
P-DMR phase of the rapid peak mediated by 16 nM BK were plotted
as a function of the concentration of HOE140 used for pretreating the
cells.
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level in cells
Since cell cholesterol level is important to many cell func-
tions including signaling, we examined the eﬀect of cholesterol
depletion by methyl-b-cyclodextrin (mbCD) on both BK-med-
iated intracellular Ca2+ modulation and DMR responses. In
the absence of EGTA – an extracellular Ca2+ chelator, the pre-
treatment of quiescent A431 cells with mbCD led to a dose-
dependent suppression of the releasing of stored Ca2+ by
16 nM BK, and at the same time dose-dependently increases
the inﬂux of extracellular Ca2+, resulting in an almost equally
elevated intracellular Ca2+ concentrations (Fig. 4A). Con-
versely, in the presence of EGTA, the intracellular Ca2+ level
increased by BK stimulation was found to be primarily medi-
ated through the releasing of stored Ca2+ and was be fully
suppressed by cholesterol depletion (data not shown).
The pretreatment of A431 with mbCD also led to a dose-
dependent alteration of the BK-mediated optical signature in
the absence of EGTA (Fig. 4B). At lower doses of mbCD
(<200 lM) BK stimulation increased the amplitude of the
rapid peak, and shortened the time reaching the central posi-
tions of the rapid peak. At intermediate doses of mbCD
between 200 and 750 lM, cholesterol depletion started to
suppress the amplitude of the rapid peak and at the same time
delayed the second peak. Conversely, at higher doses (>750 lM)
cholesterol extraction almost totally blocked the BK-mediated
responses. Previous studies showed that although B2 receptors
appear randomly distribute on the plasma membrane in A431
cells, BK stimulation results in the redistribution and seques-
tration of the receptor in caveolae, implicating that the ago-
nist-mediated endocytosis is at least partially via caveolae
[32]. The data presented here suggested that: (i) the Ca2+ in ﬂux
from extracellular environment appears not generate suﬃcient
mass redistribution; (ii) cholesterol concentration at the cell
membranes is important in BK signaling.3.5. BK-mediated optical signals are sensitive to EGFR states
Since A431 overexpresses EGFR [33] and B2 receptor signal-
ing crosstalks with EGFR [21,24], we studied the cross-
communication between the two receptors. Pretreatment of
quiescent A431 cells with EGF altered the BK-mediated opti-
cal signals (Fig. 5A). At 8 nM EGF, BK stimulation triggered
a signiﬁcant increase in both amplitudes and kinetics of the ra-
pid peak and at the same time suppressed the second retarded
peak. Conversely, 32 nM EGF signiﬁcantly suppressed both
peaks mediated by BK. Similarly, the pretreatment with BK
attenuated the EGF-mediated response in a dose-dependent
manner, and the co-pretreatment of quiescent cells with 100 nM
BK and a potent and speciﬁc PKC inhibitor GF109203x had
a little eﬀect on the EGF-mediated response (Fig. 5B). These
results suggested that BK-mediated signaling in A431 transin-
activated the EGF-mediated signaling, possibly thro-ugh PKC
pathway, supporting the previous observations done by others
[24].
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Fig. 4. Cholesterol depletion aﬀecting B2 signaling. (A) The percentage
of intracellular Ca2+, manifested by the ﬂuorescence intensity of ﬂuo-3,
as a function of time before and after stimulation with 16 nM BK. The
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Fig. 5. The cross-communications between EGFR and B2 receptor
signaling. (A) The dynamic optical signals of quiescent A431 cells
mediated by 16 nM BK in the absence (HBSS) and presence of 8 nM
EGF or 32 nM EGF. The BK solution was introduced after 1 h
treatment with EGF. (B) The eﬀect of BK on the 32 nM EGF-induced
DMR responses, as plotted by the amplitude of the N-DMR signal
mediated by EGF (14) as a function of BK concentrations: 0, 16, 64,
and 100 nM BK. The EGF-triggered cell response after sequentially
pretreated with 1 lM GF109203x and 100 nM BK (each separated by
at least 45 min) (GF+Brad) was also included for deciphering the
mechanism of BK on the EGF-mediated signaling.
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Gq-mediated signaling
BK-mediated B2 receptor activation results in signaling from
two classes of the receptor-coupled G proteins: Gq and Gs [20].
We speculated that in the BK-mediated optical signature the
rapid peak and the delayed peak are associated with Gq and
Gs, respectively. To test this hypothesis, we examined the eﬀect
of modulators that targets Gq-mediated signaling pathway
ﬁrst. The modulators used were cell-permeable and intracellu-
lar Ca2+ chelator BAPTA-AM [34], and a potent PKC inhib-
itor GF109203x [35] (Fig. 6A). Both BAPTA-AM and
GF109203x signiﬁcantly but not totally suppressed the rapid
peak. Remarkably, high dose GF109203x not only suppressed
the rapid peak, but also increased the amplitude of the second
and delayed peak. The diﬀerence between two modulators lies
on the distinct mechanisms aﬀecting the Gq-mediated signal-
ing. BAPTA-AM not only leads to sequestration of intracellu-
lar Ca2+, but also has a potent actin and microtubule
depolymerizing activity that is completely independent of
Ca2+ chelation in most cell types [34]. Thus, the eﬀect of BAP-TA-AM on the BK-mediated response may not solely due to
the chelation of intracellular Ca2+. Conversely, the inhibition
of PKC activity abolishes the activation of its downstream sig-
naling cascades, thus altering the cell responses. Alternatively,
the modulation of PKC activity might also regulate the Ca2+
mobilization. To test that, we measured the eﬀect of PKC
inhibition on the Ca2+ mobilization. Results showed that the
pretreatment of cells with the PKC inhibitor GF109203x atten-
uated the BK-mediated Ca2+ mobilization (Fig. 6B), suggest-
ing that the second mechanism is likely to regulate the
overall mass redistribution through the Gq-mediated signaling.
To examine the involvement of Gs-mediated signaling in the
overall optical signature induced by BK, we further examined
the eﬀect of cAMP-PKA pathway modulators on the BK-
mediated responses (Fig. 7A). Pretreatment of cells with
KT5720 abolished the second and delayed peak, and increased
the rapid response by 47 ± 4.3% (n = 3). KT5720 is a potent
and selective inhibitor of PKA [36]. On the other hand, both
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Fig. 6. The Gq-mediated B2 signaling. (A) The dynamic optical
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Fig. 7. The Gs-mediated B2 signaling. (A) The dynamic optical
signatures of quiescent cells mediated by 16 nM BK in the absence (a)
and presence of 1 lM KT5720 (b), 10 lM forskolin (c), or 10 lM
milrinone (d). (B) The percentage increase of intracellular Ca2+,
manifested by the ﬂuorescence intensity of ﬂuo-3, as a function of the
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(control), 10 lM 8-bromo-cAMP, 10 lM NKH447, 10 lM forskolin,
or 10 lM KT5720 before 16 nM BK stimulation. (C) The amplitudes
of the P-DMR phase of the rapid peak mediated by 100 nM BK were
plotted as a function of compounds. The proliferating cells (15% FBS)
were pretreated individually with 1·HBSS (control), 10 lMmilrinone,
10 lM zardaverine, 10 lM rolipram, or 10 lM forskolin for 1 h before
BK stimulation.
6370 Y. Fang et al. / FEBS Letters 579 (2005) 6365–6374forskolin and milrinone led to almost total suppression of the
rapid peak and increased the amplitude of the second peak.
Milrinone is a selective and potent PDE3 inhibitor; the inhibi-
tion of PDE3 suppresses the ability of PDE3 to degrade the
cAMP [37–39], thus counteracting the Gq-mediated signaling.
These results suggested that in A431 cells B2 signaling involves
both Gs and Gq signaling. However, pretreatment of quiescent
cells with either of these modulators had little eﬀect on the BK-
mediated Ca2+ mobilization (Fig. 7B), suggesting that either
inhibition or activation of PKA did not alter the amplitude
of Ca2+ mobilization through Gq, rather, indirectly impacted
their downstream cellular activities.
However, proliferating cells gave rise to further increased
amplitude (approximate 16%) of the 100 nM BK-mediated
rapid peak after individually pretreated with milrinone,
zardaverine, rolipram and forskolin (Fig. 7C). This was con-
tradictory to those of quiescent cells, suggesting that at high
doses BK stimulation of proliferating cells led to responses
via probably Gi – rather than Gs-coupled signaling, besides
Gq-coupled signaling.
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Fig. 8. Endocytosis and B2 signaling. The dynamic optical signatures
of quiescent cells mediated by 16 nM BK in the absence (a) and
presence of 10 lM cytochalasin B (b), 50 lM dynamin inhibitory
peptide DIPC (c), or 20 lM latrunculin A (d).
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modulators
Since optical biosensor is sensitive to ligand-mediated mass
redistribution and many important aspects of cell activities
including traﬃcking and morphological changes require the
rearrangement of cytoskeleton structure [3–10], we were inter-
ested in the roles of cytoskeleton modulation in the BK-
induced optical responses (Fig. 8). Pretreatment of A431 with
latrunculin A signiﬁcantly suppressed both peaks, whereas
cytochalasin B was much less eﬀective in suppressing the res-
ponses. This diﬀerence may lie in their diﬀerent mechanisms
to cause actin disassembly: cytochalasin B caps actin ﬁlaments
[40], while latrunculin A sequesters actin monomers [41]. Such
a diﬀerence may lead to distinct abilities for each toxin to
modulate the receptor signaling by either aﬀecting the endocy-
tosis or the assembly of signaling machineries [42]. Conversely,
neither a stabilizing polymeric F-actin agent phalloidin nor a
microtubule disrupter nocodazole had any eﬀect on the res-
ponse (data not shown).
Since certain dynamin isoforms are localized with actin ﬁla-
ments, and is considered to play a critical role in the receptor-
mediated endocytosis and cell signaling [43–45], the cells were
pretreated with a cell permeable dynamin inhibitory peptide
DIPC. Results showed that DIPC completely abolished the
rapid peak, but not the second retarded peak (Fig. 8), suggest-
ing that Gq-mediated signaling is dependent on the receptor-
mediated endocytosis [45].4. Discussions
4.1. Nature of the BK-mediated optical signature
Resonant waveguide grating (RWG) biosensor is a label free
technology, and is sensitive to change in local refractive index
in the vicinity of the sensor surface [46]. Such a change is di-
rectly proportional to redistribution in local mass density
and amount, due to intracellular molecules or molecular
assemblies moving into or out of the sensing volume – anintrinsic property of the sensor which is determined by the
sensor conﬁguration and generally small (120 nm for the sen-
sors used in this study). Since the biosensor is mostly sensitive
to the mass redistribution parallel to the direction of the eva-
nescent wave of the sensors but perpendicular to the sensor
surface, the resulted optical signal is referred to directional
mass redistribution (DMR). Because of its dynamic nature,
it is also referred to dynamic mass redistribution (DMR). A
net increase in mass at appropriate time within the sensing
volume results in an increase in the angle of the reﬂected light
(i.e., an increased signal); vice versa, a net decrease in mass
leads to a decrease in the angle (i.e., a decreased signal), when
an angular interrogation detection system is used.
GPCR signaling leads to numerous events that could result in
dynamic mass redistribution. In A431 cells, the notable mass
redistribution events include the membrane targeting of intra-
cellular targets to the activated receptors and/or other adaptor
molecules such as b-arrestin, receptor-mediated endocytosis
and signaling, cytoskeleton remodeling (e.g., cell morphological
changes), and the locally generated second messengers (e.g.,
IP3, Ca
2+, cAMP). However, each of these events contributes
unequally to the overall response, because of the nature of the
evanescent wave of the electromagnetic ﬁeld generated by the
coupled light propagated parallel to the sensor surface. The
mass redistribution parallel to the sensor surface generally re-
sults in much less contribution to the overall response if any
than that perpendicular to the sensor surface. The mass redistri-
bution closer to the sensor surface contributes much more than
that further away from the sensor surface. The generation of
second messengers themselves (e.g., Ca2+ ﬂux or cAMP accu-
mulation), even locally whether through Gq- or Gs-mediated
signaling, appears not lead to any detectable mass redistribu-
tion, because the changes in local refractive index within the
sensing volume is largely determined by the changes in protein
concentrations [47,48]. The signiﬁcant inhibition of the rapid
peak in the BK-mediated signal by GF109203x, coupled with
its less dramatic eﬀect on the Ca2+ ﬂux, suggested that Gq-med-
iated Ca2+ mobilization itself does not generate signiﬁcant mass
redistribution, at least within the sensing volume. Similarly, the
Gs-mediated cAMP accumulation itself also does not lead to
any detectable mass redistribution, as evidenced by observation
that the inhibition of PKA activity by KT5720 suppressed the
second and retarded peak relating to the Gs-mediated signaling.
PKA is a downstream target of cAMP.
The uniqueness of the DMR signal obtained using optical
biosensor is that it is an integrated cell response in terms of
mass redistribution within the sensing volume of the sensor.
The eﬀect of modulators of various cellular targets on the
BK-mediated DMR signal provides information about the
involvement of the targets on mass redistribution, thus indicat-
ing the participation of the targets in the receptor signaling.
The availability of a wide array of modulators on numerous
targets opens the possibility for the use of optical biosensor
to map the receptor signaling and network interactions.4.2. BK stimulation triggers unique optical signatures via speciﬁc
activation of B2 receptor
BK stimulation of A431 cells led to dynamic mass redistri-
bution, as monitored in real time by RWG biosensor, which
depends on the cell culture conditions. Proliferating cells
responded to low dose BK stimulation with only a slow
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identical signature to those stimulated with a PKA activator
8-bromo-cAMP, as well as two adenylyl cyclase activators
forskolin and NKH447 (Fig. 2; data not shown), suggesting
that BK stimulation only triggered cAMP accumulation.
However, at higher doses BK stimulation of proliferating cells
gave rise to a DMR signal that only exhibited the rapid peak,
suggesting that under those conditions BK stimulation favors
Gq signaling through B2 receptor activation.
In contrast, quiescent A431 cells obtained with 0.05% FBS
gave rise to a DMR signal with dual peaks, a ﬁrst and rapid
peak and a second and delayed peak, in response to stimulation
with BK at concentrations between 2 and 64 nM (Fig. 1A).
Further analysis suggested that under those conditions BK
stimulation activates B2 receptor, leading to at least dual signal-
ing pathways – Gs and Gq-mediated signaling pathways (see be-
low). However, at high doses BK stimulation led to a DMR
response that only presents the rapid peak (Fig. 1D). This is
probably due to the switching of Gs- to Gi-coupled signaling
[20,26–28], as suggested by the eﬀect of PDEs inhibitors milri-
none, zardaverine and rolipram on the optical signature of
proliferating cells mediated by 100 nM BK (Fig. 7C). The pre-
treatment of A431 with either compound further increased the
amplitude of the ﬁrst rapid peak by approximately 16%,
compared to the BK stimulation alone. This eﬀect is contradic-
tory to those of the quiescent cells stimulated with 16 nM BK.
The BK-mediated DMR responses were speciﬁc to B2 recep-
tor activation in A431 cells, as demonstrated by both the sat-
urability to BK concentrations, and the ability of a B2-
speciﬁc antagonist HOE 140, but not a B1-speciﬁc antagonist
des-Arg10-HOE140, to inhibit the DMR responses in a dose-
dependent manner (Fig. 3).4.3. BK stimulation activates B2 receptor that mediates both
Gs- and Gq-coupled signaling
As shown in Fig. 7A, the pretreatment of quiescent A431
cells with a PKA inhibitor KT5720 at 1 lM only suppresses
the second and retarded peak, but increases the amplitude of
the ﬁrst and rapid peak. This is consistent with the previous
observations done by others that the Gs signaling lags, and
counteracts the Gq signaling [20]. Thus speciﬁc suppression
of Gs signaling should cause an increase in Gq signaling. In
contrast, a PKC inhibitor GF109203x at 500 nM almost
totally abolished the rapid peak, and increased the amplitude
of the second peak (Fig. 6). These results suggested that the
second and retarded peak is mainly related to the cAMP-
PKA pathway via Gs signaling, whereas the ﬁrst and rapid
peak is primarily related to the PKC pathway via Gq signaling.
This was further conﬁrmed by the eﬀect of a PDE3 inhibitor
milrinone, (Fig. 7). Milrinone resulted in an increase in intra-
cellular cAMP level, thereby attenuating the Gq signaling. As
expected, milrinone led to an increase in the amplitude of the
second peak, but almost completely abolished the ﬁrst peak.
However, neither milrinone nor adenylyl cyclase activators
had any obvious eﬀect on the BK-mediated Ca2+ ﬂux
(Fig. 7B), consistent with the previous study done by others
that cAMP has no eﬀect on PtdIns hydrolysis [20]. These re-
sults suggested that in A431 cells, B2 signaling involves both
Gs and Gq signaling. Remarkably, our studies suggested that
both signaling pathways counter-regulate each other, at least
in terms of mass redistribution mediated by BK stimulation.4.4. B2 signaling crosstalks with EGFR
A431 cells endogenously overexpress EGFR. EGFR acts
as a downstream target for numerous mitogenic GPCRs
[21,24,49–51]. Previous studies done by others [24] have shown
that in A431 the activation of B2 receptor induced by BK stim-
ulates the activity of protein-tyrosine-phosphate (PTP) and
thereby results in the transinactivation of EGFR. Thus we
were interested in the crosstalk between B2 receptor and
EGFR. The pretreatment of quiescent A431 cells with 8 nM
EGF increased the amplitude of the rapid peak relating to
Gq-coupled signaling triggered by BK stimulation, probably
through selectively turn-oﬀ of the Gs-mediated signaling [21].
However, 32 nM EGF almost completely abolished the BK-
mediated DMR responses (Fig. 5A). It is known that activa-
tion of EGFR by EGF resulted in recruitment of various
signaling components including the PLCc [52], while Gq-cou-
pled receptors are linked to the stimulation of PLCb [53]. Both
isoforms of phospholipase C (PLC) are capable of hydrolyzing
PIP2 into DAG and IP3, which in turn leads to PKC activation
and Ca2+ release. However, EGF generally induced a weak but
insigniﬁcant elevation of IP level [54]; data not shown),
whereas BK stimulation leads to more signiﬁcant Ca2+ tran-
sient (Fig. 1C). On the other hand, the pretreatment of quies-
cent cells with BK also blocked the EGF-mediated DMR
responses in a dose-dependent manner. One likely explanation
is that B2 receptor activation induced by BK counteracts the
EGF-mediated responses through transinactivation of EGFR.4.5. B2 signaling relies on cholesterol content
Cholesterol is spatially segregated to form membrane micro-
domains such as caveolae and lipid rafts in the plasma
membrane, which function to selectively compartmentalize
numerous signaling proteins [55]. Pretreatment of quiescent
A431 cells with mbCD dose-dependently attenuated the BK-
induced A431 cells (Fig. 4). Three possible mechanisms are
accountable for such inhibitory eﬀect. The ﬁrst one is due to
the partial blockage of receptor endocytosis by cholesterol
depletion [56]. Although B2 receptors are randomly distributed
at the cell plasma membrane, the activated receptors are
partially internalized via clathrin-dependent mechanism; remo-
val of cholesterol results in almost 50% less receptor internaliza-
tion. The reduced receptor traﬃcking might impair the B2
signaling, particularly the linkage of the receptor signaling to
MAPK pathway through beta-arrestin as scaﬀold [26]. How-
ever, neither MEK1/2 inhibitor U0126, nor P38 MAP kinase
inhibitors SB202190 and SB203580, nor JNK inhibitor
SP600125 signiﬁcantly impacted theBK-mediatedDMRsignals
(data not shown), suggesting that such mechanism is less likely.
The second one is due to the transactivation of EGFR by
cholesterol depletion in a ligand-independent and tyrosine
site-speciﬁc manner [57–60]. The EGFR transactivation may
lead to the suppression of B2 receptor signaling. This is likely
accounted for the impairment of Gs signaling, but not Gq
signaling, because cholesterol depletion alone can not fully
transactivates the EGFR (unpublished data; [57,58]), and pre-
treatment with 8 nM EGF only suppressed the cAMP signal-
ing but not Gq signaling (Fig. 5A).
The most likely mechanism is that in A431 cells cholesterol
extraction leads to the loss of compartmentalization of PtdIns
4,5-P2, and Gq [61,62], two important molecules for B2 receptor
signaling. The suppression of Ca2+ mobilization by cholesterol
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and Gq. However, the increased Ca
2+ in ﬂux from extracellular
environment might be due to the increased permeability of the
cell membranes after cholesterol depletion [55] and/or the acti-
vation of Ca2+ ion channel(s) via unknown mechanism(s). The
delocalization of both PtdIns 4,5-P2 and Gq results in the inhi-
bition of Gq signaling and its associated mass redistribution,
particularly the translocation of phospholipase Cs, PI3-kinases
and PKCs since the targeting of these proteins to the cell mem-
branes is through the interaction with speciﬁc PtdIns [3].
4.6. B2 signaling and endocytosis
The complete inhibition of the BK-mediated DMR by an
actin ﬁlament disruption agent latrunculin A and dynamin
inhibitory peptide DIPC suggested that cytoskeleton remodel-
ing and receptor-mediated endocytosis play important roles in
B2 signaling. Stimulation of B2 receptor in A431 cells with BK
leads to receptor endocytosis via both clathrin-dependent and
independent mechanisms; disruption of cholesterol-enriched
domains by cholesterol depletion only suppressed almost
50% of the receptor endocytosis [32]. Thus, the complete inhi-
bition of the BK-mediated DMR signals by cholesterol deple-
tion suggested that the caveolae-dependent endocytosis
involves in, but not solely determines, the overall responses.
On the other hand, dynamin is known to play important roles
in both clathrin-dependent and independent endocytosis. The
inhibition of dynamin by DIPC almost totally abolished the
Gq-, but not Gs-, coupled signaling; implicating the important
and complicate roles of dynamin in B2 signaling.
GPCRs transduce exogenous information into changes in
intracellular functions through a divergent array of pathways.
The precise network interactions and sophisticated balance be-
tween these signaling pathways lead to integrated and speciﬁc
cellular decisions of proliferation, diﬀerentiation, survival or
death. The localization of protein molecules of multiple com-
ponent signaling cascades is crucial to the speciﬁcity, duration
and amplitude of cell responses. We here demonstrated that
using label-free optical biosensor A431 cells responded to
BK stimulation with dynamic mass redistribution; its kinetics,
amplitudes and duration depend on the cell culture conditions,
the dose of BK, and the cellular context. The modulation of
the cellular context including cholesterol level, endocytic traf-
ﬁcking machineries, and signaling cascades altered the BK-
mediated DMR signal in distinct ways. Rich information
was concluded to decipher the cellular mechanisms of the
optical signature, which in turn allows global analysis of B2
receptor signaling and network interactions in A431 cells.
Our current work points to the negative cross-regulation bet-
ween Gs- and Gq-coupled signaling mediated via B2 receptor,
the important roles of cholesterol content in B2 signaling,
and the network interactions in determining a speciﬁc cell
response in terms of mass redistribution.Acknowledgements: The authors thankDr. NormanH. Fontaine for his
technical support in instrumentation, and Mrs. Ann M. Ferrie for her
contributions in cell culturing and compound storage managements.References
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